"One of the key mandates offered up by policymakers taking part in a special session at the 2007 convention entitled "How Much Does Washington Value Biotechnology Innovation" was for the industry to "define itself before others define you." Biotechnology is still a foreign word to many audiences, including policymakers and their constituents. In presenting biotechnology's potential, all its stakeholders—scientists, industry leaders and advocacy groups—must be aware of how information and scientific data translate into public opinion. This session will take a broad look at the future of biotechnology communication and draw upon recent case studies and new informational paradigms."

Objective1:"Explore the communication challenges faced by every biotechnology player and examine how public perception is influenced by the science media, popular press and industry representatives."

Objective2:Address how policymakers can better understand scientists and how scientists might enhance/evolve their image with the public and policymakers.

Objective3:Educate on the ways in which opinions are strengthened or changed by new information.